Response: Ovarian clear cell carcinoma: High risk of venous thromboembolism

Gynecologic Oncology

Volumn 118, Issue 3, 2010, Pages 317-318

  Duska, Linda R ^a   Horowitz, Neil ^b  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENOXAPARIN; HEPARIN;

ANTICOAGULANT THERAPY; BLOOD CLOTTING DISORDER; COMPRESSION; CYTOREDUCTIVE SURGERY; DIAGNOSTIC TEST; HIGH RISK PATIENT; HUMAN; LETTER; LUNG EMBOLISM; OVARIAN CLEAR CELL CARCINOMA; OVARY CARCINOMA; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROPHYLAXIS; PROTON NUCLEAR MAGNETIC RESONANCE; RISK REDUCTION; VENOUS THROMBOEMBOLISM;

EID: 77955550326     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2010.05.017     Document Type: Letter

References (4)

1. L.R. Duska, L. Garrett, M. Henretta, J.S. Ferris, L. Lee, and N. Horowitz When 'never-events' occur despite adherence to clinical guidelines: the case of venous thromboembolism in clear cell cancer of the ovary compared with other epithelial histologic subtypes Gynecol Oncol 116 2010 374 377
2. M.C. Lim, H.S. Lee, S. Kang, S.S. Seo, B.Y. Lee, and S.Y. Park Minimizing tumor burden by extensive cytoreductive surgery decreases postoperative venous thromboembolism in ovarian clear cell carcinoma Arch Gynecol Obstet 281 2010 329 334
3. P. Stanwell, P. Russell, J. Carter, S. Pather, S. Heintze, and C. Mountford Evaluation of ovarian tumors by proton magnetic resonance spectroscopy at three Tesla Invest Radiol 43 10 2008 745 751
4. T. Satoh, A. Oki, K. Uno, M. Sakurai, H. Ochi, and S. Okada High incidence of silent venous thromboembolism before treatment in ovarian cancer Br J Cancer 97 2007 1053 1057